None listed
Conditions
Brief summary
The aim is to assess the effectiveness and cost-effectiveness of a nurse-led, tailored survivorship care intervention using telehealth delivery, relative to ‘Information Only’ and ‘Usual Care’, for improving health-related quality of life (HRQoL) in people with Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. Who it focuses on: Patients within four weeks of completion of treatment with curative intent for HL, or aggressive NHL. Others include speaking and reading English; 18 years of age or older; an ambulatory patient at the time of recruitment; Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1; and have access to the Internet and a smart device and/or computer. Study Details: Recruited patients will be randomly allocated to one of the three arms. . The intervention group will receive the nurse-led tailored Survivorship Care intervention between the last cycle of chemotherapy and four weeks post treatment completion for people who have completed their defined active treatment for Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma. In total, this group will receive three nurse-led consultations via video conferencing. The first consultation will be 60 minutes, involving the provision of treatment summary, evidence-based patient education, survivorship care plan, follow up schedule, and appropriate patient referrals. The second and third consultation will take 30 minutes each. These 30 minute consultations will focus on patient education and amendment to the care plan depending on the needs of the individual patient. The ‘Information Only’ group will receive an evidence-based information booklet via post at the end of treatment. The booklet is entitled "Post-treatment Wellness Booklet for Patients diagnosed with Hodgkin's and Non-Hodgkin's Lymphoma". This booklet is designed by the Cancer Nursing Professorial Precinct Team, Royal Brisbane and Women's Hospital in collaboration with Queensland University of Technology and the Leukaemia Foundation. The control group will receive usual care. Usual care is the absence of any structured survivorship intervention, involving traditional physician follow up.
Interventions
Group 1: Nurse-led, tailored, survivorship care intervention using telehealth delivery
At 4 weeks following end of treatment (e.g. chemotherapy or radiotherapy), participants will be offered an initial 60 minute tailored nurse video consultation.
Subsequently, monthly 30 minute video consultation follow-up sessions at 8 weeks and 12 weeks.
During the 4 week consultation (60 minutes):
- Evidence-based Patient Education: this includes the provision of a booklet including evidence-based coping or
Group 1: Nurse-led, tailored, survivorship care intervention using telehealth delivery At 4 weeks following end of treatment (e.g. chemotherapy or radiotherapy), participants will be offered an initial 60 minute tailored nurse video consultation. Subsequently, monthly 30 minute video consultation follow-up sessions at 8 weeks and 12 weeks. During the 4 week consultation (60 minutes): - Evidence-based Patient Education: this includes the provision of a booklet including evidence-based coping or management strategies, and available healthcare resources. The booklet is entitled "Post-treatment Wellness Booklet for Patients diagnosed with Hodgkin's and Non-Hodgkin's Lymphoma". This booklet is designed by the Cancer Nursing Professorial Precinct Team, Royal Brisbane and Women's Hospital in collaboration with Queensland University of Technology and the Leukaemia Foundation. The nurse will discuss specific components of the topic that are relevant to the patient as identified by the Distress Thermometer and Problem Checklist. The Distress Thermometer and Problem Checklist will be completed by the patient prior to the consultation. - Treatment Summary and Survivorship Care Plan: The nurse will develop a post-treatment care plan in collaboration with the patient. In this care plan, it includes a treatment summary (details of lymphoma treatment received by the patient), a follow-up schedule; collaborative goal setting. - Patient referrals (as appropriate): The nurse will also facilitate referrals for the patients to receive services as appropriate. During the 8 and 12 week consultations (30 minutes each), The survivorship care plan will be reviewed as informed by the Distress Thermometer and Problem Checklist completed by patients prior to the consultations. Patient education and referrals will also be facilitated accordingly if required. - Log of all consultations will be kept by treating nurse
Sponsors
Prof Raymond Chan
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients within four weeks of completion of treatment with curative intent for Hodgkin's Lymphoma, or aggressive Non- Hodgkin's Lymphoma. Patients completing allogeneic hematopoietic stem cell transplantation, treatment completion will be defined as Day 100 (D100). Patients must be able to speak and read English. Patients must be 18 years of age or older and an ambulatory patient at the time of recruitment. Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 and also have access to the Internet and a smart device and/or computer.
Exclusion criteria
The presence of severe mental, cognitive or physical conditions that would limit the person’s ability to participate, or if they were previously enrolled into the study.
Outcome results
None listed